Editorial, J Clin Exp Oncol Vol: 1 Issue: 2
Probiotics, the New Approach for Cancer Prevention and/or Potentialization of Anti-Cancer Treatment?
|Medical University in Bialystok, Poland|
|Corresponding author : Urszula Daniluk
Department of Pediatrics, Gastroenterology and Allergology Medical University in Bialystok, Waszyngtona St. 17, 15-274 Bialystok, Poland
Tel: +48 857450710; Fax: +48 857423841
E-mail: [email protected]
|Received: September 24, 2012 Accepted: September 24, 2012 Published: September 28, 2012|
|Citation: Daniluk U (2012) Probiotics, the New Approach for Cancer Prevention and/or Potentialization of Anti-Cancer Treatment? J Clin Exp Oncol 1:2. doi:10.4172/2324-9110.1000e105|
Probiotics, the New Approach for Cancer Prevention and/or Potentialization of Anti-CancerTreatment?
Uncontrolled proliferation of the cells and their resistance to programmed cell death are main features of malignant cells. The effectiveness in the treatment of cancers is based on the restoration of the sensitivity of transformed cells to apoptotic signals. Although significant progress has been made in this field during last decades, the resistance to chemotherapy becomes a problem in many cases. The association between cancer and modifiable health behaviors is well supported. At least one-half of all cancers are suggested to have a dietary component. Therefore many of the dietary agents and natural health products have attracted the attention of scientists. One of them is probiotics, the nonpathogenic microorganisms living in the intestinal tract which benefit the host. In human clinical trials, probiotics has been used successfully in the treatment of acute diarrhea. Other clinical indications for probiotics, mainly in inflammatory bowel disease, are still evaluated with promising preliminary data.